Ostatní
Návod 
Neurocrine Biosciences, Inc.
NBIX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
14.6B
Obrat
3B
Zisk
0B
Aktiva
4B
Dluh
0B
ROE
0%
ROA
0%
PE
26
PS
4
Cena 1R
84-160
⌀ Cena
132.19
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
11-02-2026
Poslední dividenda
Profil
Neurocrine Biosciences, Inc. objevuje, vyvíjí a prodává léčiva pro neurologické, endokrinní a psychiatrické poruchy. Portfolio společnosti zahrnuje léčbu tardivní dyskineze, Parkinsonovy nemoci, endometriózy a děložních fibroidů, stejně jako klinické programy v různých terapeutických oblastech. Jeho hlavním aktivem je INGREZZA, inhibitor VMAT2 pro léčbu tardivní dyskineze. Mezi komerční produkty společnosti patří ONGENTYS, inhibitor katechol-O- methyltransferázy používaný jako doplňková léčba k inhibitorům levodopa/DOPA dekarboxylázy u pacientů s Parkinsonovou nemocí; ORILISSA k léčbě středně těžké až těžké endometriózy u žen; a ORIAHNN, nechirurgická perorální léčba k léčbě těžkého menstruačního krvácení spojeného s děložními fibroidy u žen před menopauzou. Mezi jeho produkty, které lze použít v klinickém vývoji, patří NBI- 921352 pro léčbu pediatrických pacientů, stejně jako pro fokální indikace u dospělých epilepsií a NBI- 827104 pro léčbu vzácné pediatrické epilepsie a esenciálního tremoru. Produkty společnosti v klinickém vývoji také zahrnují NBI-1065845 pro léčbu depresivní poruchy; NBI-1065846 pro léčbu anhedonie u depresivní poruchy; a NBI-118568 pro léčbu schizofrenie. Má licenční smlouvy a smlouvy o spolupráci se společností Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL _x0096_ Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; a AbbVie Inc. Neurocrine Biosciences, Inc. byla založena v roce 1992 a sídlí v kalifornském San Diegu.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
1800
Založení
1996-05-23
Podobné společnosti
$ 70.48
+ $ 0.38
$ 22.10
+ $ 0.61
$ 10.03
- $ 0.09
$ 13.49
+ $ 0.03
$ 157.55
- $ 1.59
$ 220.64
- $ 8.59
$ 17.99
- $ 0.20
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,860.5 | 2,860.5 | 2,355.3 | 1,887.1 | 1,488.7 | 1,133.5 | 1,045.9 | 788.1 | 451.2 | 161.6 | 15.0 | 19.8 | 0.0 | 2.9 | 53.1 | 77.4 | 33.5 | |
| Cost of Revenues | 52.1 | 52.1 | 34.0 | 39.7 | 23.2 | 14.3 | 10.1 | 7.4 | 4.9 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 2,808.4 | 2,808.4 | 2,321.3 | 1,847.4 | 1,465.5 | 1,119.2 | 1,035.8 | 780.7 | 446.4 | 160.4 | 15.0 | 19.8 | 0.0 | 2.9 | 53.1 | 77.4 | 33.5 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 805.5 | 794.9 | 687.5 | 572.6 | 627.7 | 622.1 | 590.2 | 515.3 | 515.2 | 498.8 | |
| Cost of Revenues | 17.6 | 14.0 | 11.3 | 9.2 | 9.3 | 8.0 | 9.2 | 7.5 | 8.5 | 11.2 | |
| Gross Profit | 787.9 | 780.9 | 676.2 | 563.4 | 618.4 | 614.1 | 581.0 | 507.8 | 506.7 | 487.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 565.0 | 463.8 | 328.1 | 275.0 | 200.0 | 160.5 | 121.8 | 94.3 | 81.5 | 46.4 | 39.2 | 37.2 | 31.0 | 31.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 887.6 | 752.7 | 583.3 | 433.3 | 354.1 | 248.9 | 169.9 | 68.1 | 32.5 | 18.0 | 13.3 | 13.4 | 12.5 | 16.1 | |
| Depreciation & Amortization | 30.1 | 30.1 | 27.1 | 21.3 | 15.6 | 10.9 | 8.6 | 7.5 | 4.0 | 2.4 | 1.5 | 1.0 | 0.8 | 0.7 | 0.7 | 0.7 | 1.4 | |
| Total Operating Expenses | 2,189.3 | 2,189.3 | 1,750.8 | 1,596.5 | 1,216.5 | 911.4 | 708.3 | 554.1 | 409.5 | 291.7 | 162.4 | 114.0 | 64.4 | 52.6 | 51.7 | 43.4 | 47.2 | |
| Operating Income | 619.1 | 619.1 | 570.5 | 250.9 | 249.0 | 196.9 | 318.9 | 219.1 | 36.9 | -131.4 | -147.4 | -94.2 | -64.4 | -49.7 | 1.4 | 33.9 | -13.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 137.5 | 142.2 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 218.9 | 204.2 | ||
| Depreciation & Amortization | 7.5 | 7.7 | 7.3 | 7.6 | 7.1 | 6.5 | 7.3 | 6.2 | 5.7 | 5.5 | ||
| Total Operating Expenses | 577.0 | 541.9 | 530.6 | 539.8 | 476.4 | 430.3 | 435.6 | 408.5 | 356.4 | 346.4 | ||
| Operating Income | 210.9 | 239.0 | 145.6 | 23.6 | 142.0 | 183.8 | 145.4 | 99.3 | 150.3 | 141.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 90.3 | 91.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 | 1.9 | 0.6 | 0.4 | 0.5 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 126.6 | 4.6 | 7.1 | 25.8 | 32.8 | 32.0 | 30.5 | 19.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.0 | |
| Other Expense | 86.3 | 86.3 | -84.5 | 81.2 | -35.1 | -95.5 | -212.2 | -172.6 | 15.5 | 8.3 | 6.3 | 5.3 | 3.9 | 3.6 | 3.6 | 3.6 | 5.8 | |
| IBT | 705.4 | 705.4 | 486.0 | 332.1 | 213.9 | 101.4 | 106.7 | 46.5 | 21.8 | -142.5 | -141.1 | -88.9 | -60.5 | -46.1 | 5.0 | 37.6 | -8.0 | |
| Income Tax Expense | 226.8 | 226.8 | 144.7 | 82.4 | 59.4 | 11.8 | -300.6 | 9.5 | 0.7 | 17.1 | -7.7 | -6.3 | -4.7 | -4.2 | -4.2 | -4.3 | 0.0 | |
| Net Income | 478.6 | 478.6 | 341.3 | 249.7 | 154.5 | 89.6 | 407.3 | 37.0 | 21.1 | -142.5 | -141.1 | -88.9 | -60.5 | -46.1 | 5.0 | 37.6 | -8.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -42.8 | 22.2 | 20.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 15.6 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 49.7 | 1.1 | 1.1 | 1.1 | ||
| Other Expense | 28.5 | 52.8 | 13.9 | -8.9 | 20.6 | 6.5 | -46.8 | -64.8 | 47.9 | -25.6 | ||
| IBT | 239.4 | 291.8 | 159.5 | 14.7 | 162.6 | 190.3 | 98.6 | 34.5 | 198.2 | 115.6 | ||
| Income Tax Expense | 85.7 | 82.3 | 52.0 | 6.8 | 59.5 | 60.5 | 33.6 | -8.9 | 50.5 | 32.5 | ||
| Net Income | 153.7 | 209.5 | 107.5 | 7.9 | 103.1 | 129.8 | 65.0 | 43.4 | 147.7 | 83.1 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.56 | $1.61 | $0.95 | $4.38 | $0.40 | $0.23 | $-1.62 | $-1.63 | $-1.05 | $-0.81 | $-0.69 | $0.08 | $0.68 | $-0.15 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.47 | $1.56 | $0.92 | $4.16 | $0.39 | $0.22 | $-1.62 | $-1.63 | $-1.05 | $-0.81 | $-0.69 | $0.08 | $0.67 | $-0.15 | |
| Shares Outstanding | 99.5 | 99.5 | 100.4 | 97.7 | 95.8 | 94.6 | 93.1 | 91.6 | 90.2 | 88.1 | 86.7 | 84.5 | 74.6 | 67.0 | 65.6 | 55.2 | 52.8 | |
| Diluted Shares Outstanding | 102.5 | 102.5 | 103.7 | 101.0 | 98.9 | 97.9 | 97.8 | 95.7 | 95.4 | 88.1 | 86.7 | 84.5 | 74.6 | 67.0 | 66.9 | 56.3 | 52.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.50 | $0.85 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.44 | $0.82 | ||
| Shares Outstanding | 99.5 | 99.4 | 99.0 | 99.7 | 100.0 | 101.1 | 100.8 | 99.8 | 98.4 | 97.9 | ||
| Diluted Shares Outstanding | 102.5 | 102.5 | 101.0 | 102.5 | 102.9 | 104.3 | 103.9 | 103.6 | 102.3 | 101.1 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 139.7 | 233.0 | 251.1 | 262.9 | 340.8 | 801.0 | 112.3 | 141.7 | 254.7 | 83.3 | 74.2 | 31.0 | 44.8 | 63.8 | 50.1 | 54.1 | |
| Short Term Investments | 899.2 | 843.1 | 780.5 | 726.4 | 370.5 | 613.9 | 558.2 | 509.2 | 261.2 | 224.1 | 305.0 | 162.8 | 101.0 | 109.3 | 79.0 | 72.8 | |
| Total Cash & ST Investments | 1,038.9 | 1,076.1 | 1,031.6 | 989.3 | 711.3 | 801.0 | 670.5 | 650.9 | 515.9 | 307.4 | 379.2 | 193.8 | 145.7 | 173.0 | 129.1 | 126.9 | |
| Accounts Receivable | 468.2 | 479.1 | 439.3 | 350.0 | 185.5 | 157.1 | 126.6 | 56.2 | 31.1 | 0.0 | 0.0 | 0.0 | 0.0 | 14.1 | 1.9 | 4.5 | |
| Inventory | 42.5 | 57.4 | 38.3 | 35.1 | 30.5 | 28.0 | 17.3 | 10.9 | -31.1 | 0.0 | 0.0 | 0.0 | 0.0 | -14.1 | 0.0 | 0.0 | |
| Other Current Assets | 120.2 | 112.1 | 97.8 | 464.2 | 261.5 | 215.2 | 160.5 | 86.9 | 39.0 | 3.1 | 4.9 | 4.4 | 2.7 | 16.3 | 1.5 | 1.7 | |
| Total Current Assets | 1,669.8 | 1,724.7 | 1,607.0 | 1,453.5 | 972.8 | 1,016.2 | 831.0 | 737.8 | 554.9 | 310.4 | 384.1 | 198.2 | 148.5 | 189.3 | 132.5 | 133.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 340.2 | 264.0 | 194.1 | 233.0 | 349.1 | 139.7 | 396.3 | 251.1 | 293.7 | 160.2 | |
| Short Term Investments | 774.6 | 711.6 | 749.4 | 843.1 | 878.9 | 899.2 | 814.3 | 780.5 | 801.4 | 816.5 | |
| Total Cash & ST Investments | 1,114.8 | 975.6 | 943.5 | 1,076.1 | 1,228.0 | 1,038.9 | 1,210.6 | 1,031.6 | 1,095.1 | 976.7 | |
| Accounts Receivable | 728.0 | 595.7 | 516.0 | 479.1 | 481.1 | 468.2 | 450.7 | 439.3 | 417.8 | 387.6 | |
| Inventory | 69.3 | 56.9 | 59.1 | 57.4 | 45.8 | 42.5 | 37.2 | 38.3 | 28.8 | 31.7 | |
| Other Current Assets | 246.3 | 120.7 | 119.3 | 112.1 | 121.7 | 120.2 | 100.5 | 97.8 | 108.2 | 100.6 | |
| Total Current Assets | 2,158.4 | 1,748.9 | 1,637.9 | 1,724.7 | 1,876.6 | 1,669.8 | 1,799.0 | 1,607.0 | 1,649.9 | 1,496.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 343.0 | 592.0 | 347.3 | 145.6 | 155.8 | 127.4 | 116.2 | 33.9 | 10.8 | 6.3 | 3.4 | 2.5 | 1.8 | 1.9 | 1.6 | 1.5 | |
| Goodwill | 5.7 | 5.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 33.5 | 36.5 | 35.5 | 37.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.4 | 0.0 | |
| Long-Term Investments | 789.4 | 864.3 | 849.4 | 401.5 | 624.4 | 265.3 | 355.6 | 216.0 | 247.4 | 43.5 | 82.5 | 37.5 | 0.0 | 0.5 | -343.7 | 3.7 | |
| Other Long-Term Assets | 49.8 | 9.8 | 49.6 | 25.0 | 4.4 | 6.4 | 3.2 | 5.5 | 4.5 | 4.9 | 4.8 | 4.8 | 4.4 | 4.3 | 4.3 | 6.1 | |
| Total Long-Term Assets | 1,635.2 | 1,994.0 | 1,644.4 | 915.2 | 1,099.7 | 718.5 | 475.0 | 255.4 | 262.7 | 54.6 | 90.7 | 44.8 | 6.2 | 6.7 | 5.9 | 11.4 | |
| Total Assets | 3,305.0 | 3,718.7 | 3,251.4 | 2,368.7 | 2,072.5 | 1,734.7 | 1,306.0 | 993.2 | 817.6 | 365.1 | 474.8 | 243.0 | 154.7 | 196.0 | 138.4 | 144.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 566.2 | 584.0 | 589.2 | 592.0 | 337.3 | 343.0 | 346.1 | 347.3 | 149.6 | 149.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.8 | 0.0 | 0.0 | |
| Intangible Assets | 35.7 | 37.2 | 36.4 | 36.5 | 34.5 | 33.5 | 34.3 | 35.5 | 34.9 | 36.9 | |
| Long-Term Investments | 118.1 | 961.3 | 909.5 | 864.3 | 770.6 | 781.4 | 863.9 | 849.4 | 587.5 | 515.6 | |
| Other Long-Term Assets | 1,018.8 | 21.6 | 15.3 | 15.5 | 61.6 | 57.8 | 50.9 | 49.6 | 43.1 | 35.9 | |
| Total Long-Term Assets | 2,107.3 | 2,140.9 | 2,049.8 | 1,994.0 | 1,658.4 | 1,635.2 | 1,673.4 | 1,644.4 | 1,198.3 | 1,116.5 | |
| Total Assets | 4,265.7 | 3,889.8 | 3,687.7 | 3,718.7 | 3,535.0 | 3,305.0 | 3,472.4 | 3,251.4 | 2,848.2 | 2,613.1 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 107.2 | 110.0 | 108.9 | 76.3 | 51.5 | 39.4 | 46.2 | 13.8 | 5.6 | 5.1 | 2.6 | 0.2 | 0.1 | 0.9 | 1.1 | 0.8 | |
| Short-Term Debt | 35.4 | 0.0 | 170.1 | 169.4 | 0.0 | 0.0 | 408.8 | 62.3 | 38.4 | 14.9 | 12.5 | 0.0 | 0.0 | 11.2 | 8.5 | 8.6 | |
| Other Current Liabilities | 255.9 | 397.7 | 351.4 | 292.0 | 194.3 | 147.1 | 156.5 | 1.9 | 0.2 | 0.2 | 0.4 | 15.4 | 11.6 | 0.6 | 0.3 | 3.4 | |
| Current Liabilities | 398.5 | 507.7 | 654.8 | 537.7 | 245.8 | 186.5 | 565.3 | 88.2 | 54.4 | 30.4 | 25.7 | 15.7 | 11.7 | 15.6 | 47.1 | 52.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 119.9 | 104.6 | 110.0 | 110.0 | 95.7 | 107.2 | 87.3 | 108.9 | 93.8 | 391.6 | |
| Short-Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 259.0 | 202.1 | 187.7 | 187.4 | |
| Other Current Liabilities | 518.1 | 416.0 | 412.9 | 397.7 | 334.0 | 256.6 | 341.8 | 319.4 | 337.4 | 3.5 | |
| Current Liabilities | 638.0 | 546.3 | 522.9 | 507.7 | 429.7 | 398.5 | 712.9 | 654.8 | 691.6 | 582.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 256.2 | 455.1 | 258.3 | 93.5 | 440.4 | 412.3 | 86.7 | 388.5 | 369.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 256.2 | 455.1 | 258.3 | 93.5 | 105.3 | 94.4 | 86.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10.2 | -10.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 795.8 | 1,129.0 | 1,019.4 | 660.9 | 698.5 | 608.5 | 669.1 | 512.4 | 445.5 | 50.2 | 50.3 | 34.3 | 34.3 | 41.6 | 78.3 | 125.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 428.4 | 439.1 | 447.5 | 455.1 | 251.4 | 256.2 | 252.9 | 258.3 | 85.9 | 89.1 | |
| Capital Leases | 428.4 | 439.1 | 447.5 | 455.1 | 251.4 | 256.2 | 252.9 | 258.3 | 85.9 | 89.1 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 78.6 | 0.0 | 0.0 | |
| Total Liabilities | 1,262.1 | 1,195.5 | 1,152.0 | 1,129.0 | 816.1 | 795.8 | 1,086.3 | 1,019.4 | 846.1 | 760.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -48.7 | 29.2 | -157.1 | -406.8 | -635.8 | -725.4 | -1,132.7 | -1,177.8 | -1,198.9 | -1,056.3 | -915.2 | -826.3 | -765.8 | -719.7 | -724.7 | -762.3 | |
| Comprehensive Income | 2.5 | 5.8 | 7.0 | -7.9 | -1.7 | 1.8 | 1.4 | -1.9 | -1.9 | -0.3 | -1.0 | -0.3 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Total Common Equity | 2,509.2 | 2,589.7 | 2,232.0 | 1,707.8 | 1,374.0 | 1,126.2 | 636.9 | 480.8 | 372.1 | 314.9 | 424.5 | 208.7 | 120.4 | 154.4 | 60.1 | 19.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | 294.0 | 84.5 | -5.3 | 29.2 | 81.1 | -48.7 | -113.7 | -157.1 | -304.8 | -387.9 | |
| Comprehensive Income | 13.2 | 12.5 | 9.0 | 5.8 | 14.5 | 2.5 | 3.3 | 7.0 | -1.7 | -1.1 | |
| Total Common Equity | 3,003.6 | 2,694.3 | 2,535.7 | 2,589.7 | 2,718.9 | 2,509.2 | 2,386.1 | 2,232.0 | 2,002.1 | 1,853.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 291.6 | 455.1 | 428.4 | 262.9 | 440.4 | 412.3 | 495.5 | 388.5 | 369.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,509.2 | 2,589.7 | 2,232.0 | 1,707.8 | 1,374.0 | 1,126.2 | 636.9 | 480.8 | 372.1 | 314.9 | 424.5 | 208.7 | 120.4 | 154.4 | 60.1 | 19.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 3,003.6 | 2,694.3 | 2,535.7 | 2,589.7 | 2,718.9 | 2,509.2 | 2,386.1 | 2,232.0 | 2,002.1 | 1,853.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 339.2 | 478.6 | 341.3 | 249.7 | 154.5 | 89.6 | 407.3 | 37.0 | 21.1 | -142.5 | -141.1 | -88.9 | -60.5 | -46.1 | 5.0 | 37.6 | -8.0 | |
| Depreciation & Amortization | 24.7 | 30.1 | 27.1 | 21.3 | 15.6 | 10.9 | 8.6 | 7.5 | 4.0 | 2.4 | 1.5 | 1.0 | 0.8 | 0.7 | 0.7 | 0.7 | 1.4 | |
| Stock-Based Compensation | 173.5 | 217.9 | 195.5 | 194.3 | 173.1 | 134.2 | 100.0 | 75.3 | 58.1 | 42.5 | 28.5 | 28.4 | 10.4 | 6.8 | 5.5 | 2.9 | 3.1 | |
| Change Working Capital | -125.6 | -128.8 | -19.2 | 28.2 | -67.4 | 16.7 | -37.9 | 0.2 | -1.8 | -8.8 | 5.8 | 8.7 | 1.6 | 12.1 | -13.7 | -4.5 | -9.2 | |
| Change In Accounts Receivable | -80.7 | -210.5 | -39.8 | -89.3 | -162.2 | -28.4 | -30.5 | -69.2 | -25.1 | -31.1 | 1.8 | -0.5 | -1.7 | 13.5 | -12.9 | 2.8 | -4.3 | |
| Change In Accounts Payable | -36.7 | 160.2 | 29.0 | 64.3 | 114.6 | 56.8 | 26.9 | 54.0 | 18.2 | 27.3 | 4.4 | 9.8 | 3.7 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Change In Inventories | -2.2 | -15.3 | -19.1 | 5.4 | -2.6 | -2.5 | -10.7 | -6.4 | -3.5 | -1.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.7 | 0.0 | 0.0 | |
| Other Non-cash Items | 384.9 | 19.5 | 173.8 | -46.9 | 44.5 | 0.8 | 61.2 | 21.1 | 19.2 | 12.4 | -0.9 | 10.1 | 0.0 | -2.8 | -32.8 | -36.5 | 66.0 | |
| Cash from Operations | 530.4 | 0.0 | 0.0 | 389.9 | 339.4 | 256.5 | 228.5 | 152.1 | 101.4 | -94.3 | -106.2 | -38.0 | -47.1 | -29.6 | -35.3 | -0.7 | 49.9 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 153.7 | 209.5 | 107.5 | 7.9 | 103.1 | 129.8 | 65.0 | 43.4 | 147.7 | 83.1 | |
| Depreciation & Amortization | 7.5 | 7.7 | 7.3 | 7.6 | 7.1 | 6.5 | 7.3 | 6.2 | 5.7 | 5.5 | |
| Stock-Based Compensation | 58.6 | 53.7 | 52.8 | 52.8 | 66.4 | 41.5 | 43.1 | 44.5 | 38.1 | 47.8 | |
| Change Working Capital | 119.2 | 62.8 | -39.1 | -23.7 | 94.3 | 4.4 | -86.3 | -31.6 | -53.7 | 46.0 | |
| Change In Accounts Receivable | 38.4 | -132.3 | -79.7 | -36.9 | 2.0 | -12.9 | -17.6 | -11.3 | -21.4 | -30.4 | |
| Change In Accounts Payable | 76.5 | 55.8 | 15.5 | 12.4 | 67.7 | 39.4 | -59.5 | -18.6 | -83.0 | 124.4 | |
| Change In Inventories | -3.4 | -12.3 | 2.1 | -1.7 | -11.6 | -3.3 | -5.3 | 1.1 | -0.9 | 2.9 | |
| Other Non-cash Items | 1.2 | -274.5 | 10.9 | 33.9 | 2.9 | 10.7 | 76.8 | 83.4 | -34.9 | 33.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 123.5 | 212.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -35.8 | -34.0 | -38.2 | -28.3 | -16.5 | -23.4 | -10.9 | -14.7 | -24.8 | -6.9 | -4.1 | -1.9 | -1.6 | -0.5 | -1.0 | -0.8 | -0.3 | |
| Acquisitions | 95.1 | 0.0 | 0.0 | 0.0 | -42.7 | 4.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | |
| Investments | -1,361.7 | -1,319.8 | -1,056.1 | -1,411.2 | -628.9 | -804.7 | -735.5 | -797.2 | -546.0 | -583.4 | -298.8 | -449.1 | -257.5 | -145.3 | -166.3 | -139.1 | -89.8 | |
| Sales of Investment | 1,015.2 | 1,089.4 | 967.5 | 972.4 | 511.0 | 697.9 | 750.5 | 669.7 | 327.8 | 339.1 | 415.8 | 255.1 | 154.1 | 151.3 | 132.5 | 134.3 | 34.8 | |
| Other Investing Activities | -155.5 | 0.0 | 0.0 | 0.0 | 0.0 | -4.6 | 0.0 | -68.9 | 0.0 | 0.4 | -0.1 | 0.0 | -0.4 | -0.1 | 0.0 | 1.8 | 0.2 | |
| Cash from Investing | -382.3 | 0.0 | 0.0 | -467.1 | -177.1 | -130.2 | 4.1 | -211.1 | -242.9 | -250.9 | 112.9 | -195.8 | -105.4 | 5.3 | -34.8 | -3.5 | -54.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 2.4 | -13.2 | -12.5 | -10.7 | -7.3 | -8.1 | -11.6 | -11.2 | -5.4 | -7.6 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | 89.7 | |
| Investments | -323.0 | -408.5 | -315.1 | -273.2 | -311.8 | -232.5 | -191.7 | -320.1 | -487.2 | -362.7 | |
| Sales of Investment | 267.7 | 225.0 | 298.6 | 298.1 | 250.8 | 265.3 | 175.1 | 276.3 | 290.8 | 273.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.4 | -89.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -201.8 | -97.3 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -308.8 | 0.0 | 0.0 | 0.0 | -279.0 | -0.1 | -186.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 341.6 | 455.1 | 26.7 | 165.5 | 101.5 | 28.2 | 103.7 | 107.0 | 18.9 | 369.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 139.9 | 0.0 | 0.0 | 65.3 | 44.7 | 27.5 | 29.1 | 27.3 | 29.5 | 13.9 | 2.4 | 277.0 | 138.7 | 5.3 | 83.7 | 0.3 | 21.5 | |
| Repurchase of Common Stock | 0.0 | -167.7 | -300.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -168.9 | 0.0 | 0.0 | 65.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 502.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | -168.9 | 0.0 | 0.0 | 65.3 | -234.3 | 27.4 | -157.8 | 27.3 | 29.5 | 516.6 | 2.4 | 277.0 | 138.7 | 5.3 | 83.7 | 0.3 | 21.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 428.4 | -10.7 | -8.4 | -7.6 | 203.7 | -4.8 | -255.7 | 83.5 | 172.6 | -3.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35.4 | 18.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -17.7 | -150.0 | -300.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35.4 | 18.8 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35.4 | 18.8 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -20.5 | 480.0 | -18.1 | -11.6 | -73.3 | 153.7 | 74.8 | -31.7 | -112.0 | 171.4 | 9.1 | 43.2 | -13.8 | -19.0 | 13.6 | -3.9 | 16.7 | |
| Closing Cash Balance | 139.7 | 721.0 | 241.0 | 259.1 | 270.7 | 344.0 | 190.3 | 115.5 | 147.2 | 254.7 | 83.3 | 74.2 | 31.0 | 44.8 | 63.8 | 50.1 | 54.1 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 372.8 | 76.2 | 69.9 | -38.9 | -116.1 | 209.4 | -256.6 | 145.2 | -42.6 | 133.5 | |
| Closing Cash Balance | 721.0 | 348.2 | 272.0 | 202.1 | 241.0 | 357.1 | 147.7 | 404.3 | 259.1 | 301.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 494.6 | 748.7 | 557.2 | 361.6 | 322.9 | 233.1 | 217.6 | 137.3 | 76.6 | -101.3 | -110.3 | -39.9 | -48.8 | -30.2 | -36.3 | -1.4 | 49.6 | |
| Real Free Cash Flow | 321.1 | 530.8 | 361.7 | 167.3 | 149.8 | 98.9 | 117.6 | 62.0 | 18.5 | -143.8 | -138.8 | -68.3 | -59.1 | -37.0 | -41.7 | -4.3 | 46.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 390.8 | 214.3 | 89.5 | 54.1 | 235.2 | 149.9 | 53.0 | 119.1 | 118.1 | 204.4 | |
| Real Free Cash Flow | 332.2 | 160.6 | 36.7 | 1.3 | 168.8 | 108.4 | 9.9 | 74.6 | 80.0 | 156.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 26.4 | 56.5 | 2356.8 |
| P/S | 4.4 | 118.5 | 70.5 |
| P/B | 4.2 | 10.6 | 2015.4 |
| P/FCF | 23.8 | 27.4 | 7573.5 |
| Market cap | $14.6 | $10.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 14.1 % | 0 % |
| Debt to Income | 89.5 % | 248.4 % | 0 % |
| Debt to Free cash flow | 80.7 % | 33 % | 0 % |
| Interest expense percentage | 0 % | 14.8 % | 26.2 % |
| Current ratio | 3.4 | 7.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 15.9 % | -5.1 % | 0 % |
| ROA | 11.2 % | -2.8 % | 0 % |
| CapEx to Revenue | 1.2 % | 9.3 % | 6 % |
| RaD to Revenue | 0 % | 316.9 % | 0 % |
| ROEM | 1,589,166.7 | 429568.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 98.2 % | 96.1 % | 74.8 % |
| Operating margin | 21.6 % | -395.5 % | 35 % |
| Net margin | 16.7 % | -369.5 % | 34.1 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 102.5 mil | 85.3 mil |
| Employee count | 1.8 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
